Annual EBIT
-$21.06 M
+$3.45 M+14.07%
December 31, 2023
Summary
- As of February 12, 2025, ERNA annual earnings before interest & taxes is -$21.06 million, with the most recent change of +$3.45 million (+14.07%) on December 31, 2023.
- During the last 3 years, ERNA annual EBIT has fallen by -$13.81 million (-190.52%).
- ERNA annual EBIT is now -190.52% below its all-time high of -$7.25 million, reached on December 1, 2020.
Performance
ERNA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$24.91 M
-$20.18 M-426.67%
September 30, 2024
Summary
- As of February 12, 2025, ERNA quarterly earnings before interest & taxes is -$24.91 million, with the most recent change of -$20.18 million (-426.67%) on September 30, 2024.
- Over the past year, ERNA quarterly EBIT has dropped by -$19.27 million (-342.30%).
- ERNA quarterly EBIT is now -2355.00% below its all-time high of -$1.01 million, reached on March 1, 2020.
Performance
ERNA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$41.12 M
-$19.42 M-89.48%
September 30, 2024
Summary
- As of February 12, 2025, ERNA TTM earnings before interest & taxes is -$41.12 million, with the most recent change of -$19.42 million (-89.48%) on September 30, 2024.
- Over the past year, ERNA TTM EBIT has dropped by -$20.60 million (-100.38%).
- ERNA TTM EBIT is now -3953.52% below its all-time high of -$1.01 million, reached on March 1, 2020.
Performance
ERNA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ERNA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.1% | -342.3% | -100.4% |
| 3 y3 years | -190.5% | -368.5% | -101.1% |
| 5 y5 years | -190.5% | -368.5% | -101.1% |
ERNA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +82.8% | -635.8% | at low | -112.7% | +66.4% |
| 5 y | 5-year | -190.5% | +82.8% | -2355.0% | +71.0% | -3953.5% | +66.4% |
| alltime | all time | -190.5% | +82.8% | -2355.0% | +71.0% | -3953.5% | +66.4% |
Eterna Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$24.91 M(+426.7%) | -$41.12 M(+89.5%) |
| Jun 2024 | - | -$4.73 M(-19.3%) | -$21.70 M(+3.0%) |
| Mar 2024 | - | -$5.86 M(+4.0%) | -$21.06 M(+2.6%) |
| Dec 2023 | -$21.06 M(-14.1%) | -$5.63 M(+2.6%) | -$20.52 M(+6.1%) |
| Sep 2023 | - | -$5.49 M(+34.2%) | -$19.33 M(-8.6%) |
| Jun 2023 | - | -$4.09 M(-23.1%) | -$21.15 M(+3.4%) |
| Mar 2023 | - | -$5.32 M(+19.6%) | -$20.45 M(-16.6%) |
| Dec 2022 | -$24.50 M | -$4.44 M(-39.1%) | -$24.50 M(-12.3%) |
| Sep 2022 | - | -$7.30 M(+115.7%) | -$27.93 M(-73.8%) |
| Jun 2022 | - | -$3.38 M(-63.9%) | -$106.59 M(-5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$9.37 M(+19.1%) | -$113.27 M(-7.5%) |
| Dec 2021 | -$122.41 M(+1588.8%) | - | - |
| Dec 2021 | - | -$7.87 M(-90.8%) | -$122.41 M(+4.9%) |
| Sep 2021 | - | -$85.97 M(+754.3%) | -$116.74 M(+256.1%) |
| Jun 2021 | - | -$10.06 M(-45.6%) | -$32.79 M(+32.5%) |
| Mar 2021 | - | -$18.51 M(+738.7%) | -$24.74 M(+241.4%) |
| Dec 2020 | -$7.25 M | -$2.21 M(+9.9%) | -$7.25 M(+43.8%) |
| Sep 2020 | - | -$2.01 M(-0.6%) | -$5.04 M(+66.2%) |
| Jun 2020 | - | -$2.02 M(+99.0%) | -$3.03 M(+199.0%) |
| Mar 2020 | - | -$1.01 M | -$1.01 M |
FAQ
- What is Eterna Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Eterna Therapeutics?
- What is Eterna Therapeutics annual EBIT year-on-year change?
- What is Eterna Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Eterna Therapeutics?
- What is Eterna Therapeutics quarterly EBIT year-on-year change?
- What is Eterna Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Eterna Therapeutics?
- What is Eterna Therapeutics TTM EBIT year-on-year change?
What is Eterna Therapeutics annual earnings before interest & taxes?
The current annual EBIT of ERNA is -$21.06 M
What is the all time high annual EBIT for Eterna Therapeutics?
Eterna Therapeutics all-time high annual earnings before interest & taxes is -$7.25 M
What is Eterna Therapeutics annual EBIT year-on-year change?
Over the past year, ERNA annual earnings before interest & taxes has changed by +$3.45 M (+14.07%)
What is Eterna Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ERNA is -$24.91 M
What is the all time high quarterly EBIT for Eterna Therapeutics?
Eterna Therapeutics all-time high quarterly earnings before interest & taxes is -$1.01 M
What is Eterna Therapeutics quarterly EBIT year-on-year change?
Over the past year, ERNA quarterly earnings before interest & taxes has changed by -$19.27 M (-342.30%)
What is Eterna Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ERNA is -$41.12 M
What is the all time high TTM EBIT for Eterna Therapeutics?
Eterna Therapeutics all-time high TTM earnings before interest & taxes is -$1.01 M
What is Eterna Therapeutics TTM EBIT year-on-year change?
Over the past year, ERNA TTM earnings before interest & taxes has changed by -$20.60 M (-100.38%)